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Abstract
Object To demonstrate that adenosine triphosphate
(ATP), which provides a valuable biomarker for kidney
viability in the context of donation after cardiac death
(DCD) transplantation, can be detected by means of 31P
magnetic resonance spectroscopy (MRS) if kidneys are
perfused with oxygenated hypothermic pulsatile perfusion
(O2?HPP).
Materials and methods Porcine kidney perfusion was
carried out using a home made, MR-compatible HPP-
machine. Consequently, kidney perfusion could be per-
formed continuously during magnetic resonance imaging
and magnetic resonance spectroscopy recording. 31P MR
spectroscopy consisted of 3-dimensional chemical shift
imaging (CSI), which allowed for the detection of ATP
level in line. 31P CSI was performed at 3 tesla in 44 min
with a nominal voxel size of 6.1 cc.
Results 31P CSI enabled the detection of renal ATP when
pO2 was equal to 100 kPa. With pO2 of 20 kPa, only
phosphomonoester, inorganic phosphate and nicotinamide
adenine dinucleotide could be found. Semi-quantitative
analysis showed that ATP level was 1.3 mM in normal
kidney perfused with pO2 of 100 kPa.
Conclusions This combined technology may constitute a
new advance in DCD organ diagnostics prior to trans-
plantation, as it allows direct assessment of ATP concen-
tration, which provides a reliable indicator for organ
bioenergetics and viability. In this study, kidneys present-
ing no warm ischemia were tested in order to establish
values in normal organs. The test could be easily integrated
into the clinical environment and would not generate any
additional delay into the transplantation clinical workflow.
Keywords ATP  Oxygenated HPP  Kidney 





CSI Chemical shift imaging
CSS Cold static storage
DCD Donation after cardiac death
FFT Fast Fourier transform
HES Hydroxyethyl starch
HPP Hypothermic pulsatile perfusion
HTK Histidine-tryptophane-ketoglutarate
KPS-1 Kidney perfusion solution
mM Millimolar
MRI Magnetic resonance imaging
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MRS Magnetic resonance spectroscopy
NAD(H) Nicotinamide adenine dinucleotide
Pi Inorganic phosphate
bPi Buffer’s inorganic phosphate
oPi Organ’s inorganic phosphate
PME Phosphomonoester
pO2 Partial oxygen pressure







Transplantation using organs from donation after cardiac
death (DCD), where death has been accompanied by
possible irreversible damages due to circulatory arrest,
often increase the risk of delayed or primary non-function
of the graft [1, 2]. The possibility of using these organs,
however, might significantly increase the number of kid-
neys available for transplantation. To make optimal use of
this potential organ supply, the ischemic injury that
occurs after a period of warm ischemia (WI) needs to be
reversed. It has been demonstrated that oxygenated
hypothermic pulsatile perfusion (O2?HPP) can restore
energetic cellular levels in damaged kidneys due to pro-
longed WI [3–5].
Since Bretan et al. [6, 7] we know that only phospho-
monoester (PME) can be detected by 31P magnetic reso-
nance spectroscopy (MRS) in organs preserved under cold
static storage (CSS), [6–8] which corresponds to a condi-
tion without perfusion. The PME peak contains principally
cell membrane substrates (phosphocholine and phospho-
ethanolamine), sugar phosphate and adenosine-monophos-
phate (AMP) [9]. This latest intervenes in the synthesis of
adenosine-triphosphate (ATP). Thus, PME represents in
part a precursor energy pool that can be drawn to regen-
erate ATP during reperfusion of the kidney. Moreover, it
has been established that the ratio of PME to inorganic
phosphate (Pi), PME/Pi has a predictive value of kidney
function after the graft [6]. Hence, a minimum amount of
PME (PME/Pi ratio of 0.3 as shown by Bretan et al. [6]) is
required at the time of reperfusion to guarantee renal
function after the graft.
Precursors of ATP are found in PME, NAD(H), a-ATP and
c-ATP. Regarding ATP precursors, many authors have addi-
tionally shown that PME/Pi is difficult to interpret and cannot
be extrapolated regardless the perfusate nature [10, 11].
It was also shown that oxygenated hypothermic pulsatile
perfusion (O2?HPP) could ‘‘reanimate’’ the marginal
organs before transplantation [10, 12–15]. Therefore, a
direct measure of ATP concentration would be more
advantageous to assess organ reanimation during perfusion.
In this paper, we present the results of ATP levels at
4 C obtained with a home made O2?HPP MR-compatible
machine [16] on porcine kidneys. In our study, only kid-
neys presenting no WI were used in order to establish the
ATP level in recognized normal organs for transplantation.
It is an experiment conducted to obtain basic information
necessary for the next steps in marginal organs diagnostics.
Materials and methods
O2?HPP
The perfusion machine has been constructed using non-
magnetic materials. The drive and feed-back control sys-
tems are pneumatically controlled. Detailed description of
the system is presented elsewhere [17].
Ten kidneys from young pigs (age range: 4–5 months)
were used for this study. All animal procedures were
approved by the ethical committee of the institution’s
review board (Authorization No. 1052/3352/1). Kidneys
were removed ‘‘en-bloc’’ after cold flushing with 2 l of
histidine tryptophane ketoglutarate (HTK) solution (Cus-
todiol HTK, Dr. Franz Ko¨hler, Chemie GmbH, Ger-
many). The mean weight of the pigs was 30 kg. The mean
weight of the kidneys was 75 g. With this procedure, no
kidneys suffered from WI.
Kidneys were perfused during 8 h at 4 C, duration
generally admitted as necessary for proper reanimation [18].
The perfusion medium was KPS-1 (Organ Recovery Sys-
tems, Chicago, IL, USA) modified by the addition of 40
units of insulin per liter [19]. The perfusion medium had the
same composition as the Belzer-MP medium. In particular,
it contains 25 mM of phosphate. Organ perfusion requires 2
buffers: The first is a hydroxyethyl starch (HES) that is a
large colloid molecule (molecular weight of 100–1,000
kilodaltons), which is retained in the vascular space. The
second is a phosphate buffer that diffuses freely in the
interstitial space [20, 21]. The association of both is nec-
essary to increase the buffering capacity of the solution [22].
The maximum systolic pressure was maintained at
45 mmHg and the diastolic pressure at 15 mmHg. The
frequency depended on the vascular resistance and was
regulated based upon the vascular space.
After the 8 h of perfusion, the perfusion module was
introduced into the MRI apparatus for 1H imaging and 31P
spectroscopy acquisitions. The kidneys were continuously
perfused at 4 C during the entire MR procedure.
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Three situations were studied: the first, perfusion with
pO2 at 100 kPa (membrane oxygenator of 0.15 m
2); the
second with only surface oxygenation of the perfusate
(pO2 = 50 kPa); and the last at an initial pO2 of 20 kPa to
mimic the CSS situation.
To determine whether ATP can be resynthesized after a
period of cold ischemia, one of the kidneys perfused with
pO2 of 100 kPa was further exposed for an additional
period of 10 h of CSS (without perfusion) followed again
by 8 h of oxygenated (100 kPa) reperfusion. Three time
points after kidney harvesting could thus be obtained: at
8 h, which corresponds to cold O2?HPP condition, at 18 h
corresponding to 10 h of CSS and at 26 h corresponding
again to 8 h of O2?HPP.
31P MR spectroscopy
The measurements were performed on a clinical 3-tesla
system (Magnetom Tim-Trio, Siemens Medical Solutions,
Erlangen, Germany) with a homemade 20 cm diameter
surface coil tuned at 49.5 MHz. The coil is part of the
perfusion machine (Fig. 1). It is fixed at the bottom of
the ‘‘perfusor’’, which constitutes the disposable piece of
the perfusion device.
The coil was interfaced with a specially designed
transceiver allowing both 1H imaging and 31P spectros-
copy. 1H imaging was performed with the body coil and
consisted of a T2 sequence (turbo SE, TR 5,000 ms, TE
108 ms, 3 mm slices). The field homogeneity was opti-
mized with automatic shimming over the kidneys. 31P
MRS consisted of 3D CSI, FOV 250 9 250 9 200 mm3,
matrix size 16 9 16 9 8, nominal spatial resolution 15.6 9
15.6 9 25 mm3, TR 1,000 ms, bandwidth 2,000 Hz, 1 K
sampling points. A Hanning-weighted k-space acquisition
scheme was applied to reduce spatial contamination from
adjacent voxels while improving the signal-to-noise ratio
[23]. Reference transmitter 31P power was adjusted on non-
localized 31P spectra (TR 10,000 ms) to get maximum
buffer Pi (bPi) signal, which can be considered as homo-
geneously distributed over the surface coil. This reference
power setting used a hard pulse of 500 ls. It was fixed and
kept constant for all the experiments. For the 3D-CSI
acquisitions, a selective pulse of 3 ms was used. The pulse
amplitude was scaled automatically (part of the standard
sequence), and the flip angle was reduced to 40 degrees to
minimize T1 saturation effect. The slice thickness was kept
to the maximum (200 mm) in order to reduce the chemical-
shift artefact. The pulse duration together with the phase
encoding gradient duration produced an acquisition delay
(TE) of 2.3 ms. Finally, a frequency offset of -500 Hz
(frequency carrier was set between the c- and a-ATP res-
onances) was used to minimize the effect of the excitation
pulse bandwidth.
The kidneys were placed on a holder 2.5 cm above the
surface coil to avoid strong RF inhomogeneities (hot spots)
as well as strong B0 field inhomogeneity regions due to the
perfusor shape. The kidneys were entirely covered by
perfusion medium to minimize air-tissue susceptibility
artefacts. Kidney position with the superimposed CSI grid
are shown in Fig. 2. The same acquisition was repeated
with no kidney in order to obtain the sensitivity profile of
the surface coil.
Data were processed off line using the SAGE software
(General Electric Medical Systems, Milwaukee, WI). The
processing consisted of zero filling (2 K points), 10 Hz
gaussian apodization, and FFT. First order phase correction
and sinc spectrum deconvolution were performed to
account for the acquisition delay (2.3 ms) [24]. The spectra
located in the kidney were corrected for frequency shifts,
and averaged. Between 8 and 12 voxels were averaged to
produce a single experimental data (Fig. 2). Chemical shift
is referenced to the Pi resonance set at 5.2 ppm, corre-
sponding to buffer pH of 7.35.
Peak area (estimated by Gaussian line fitting using the
Marquardt algorithm) of the kidney were normalized to bPi
(25 mM) obtained from regions outside the kidneys. Coil
sensitivity correction was performed to account for dif-
ferences in location of kidney and buffer voxels. For each
kidney, a sensitivity correction factor (Csens) was derived
by dividing the average Pi peak integral of buffer voxels
with the average Pi peak integral of voxels corresponding
to kidney locations. In general, 2–4 buffer voxels were
used. The metabolite concentration [31Pm], expressed as
mmol/L (mM), was calculated as:
31Pm
  ¼ ðSm=SbPiÞ  31Pbuffer
   CsensFig. 1 Bottom view of the perfusor with the
31P surface coil placed
underneath the perfusor (up side down)
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where Sm and SbPi are the mean metabolite, respectively
bPi signals (area), and [31Pbuffer] is the buffer phosphate
concentration (25 mM).
The b-ATP area, which contains information exclu-
sively from ATP, was used to assess ATP levels. No cor-
rection for saturation effects (T1) was attempted.
Results
One kidney was discarded due to the presence of many
cystic lesions. The remaining nine kidneys were divided
into 3 groups of three, corresponding to three perfusion
conditions (pO2 C100 kPa, pO2 *50 kPa and initial PO2
B20 kPa). MRS examination was always performed 8 h
after harvesting.
Presence of ATP under pO2 of 100 kPa is demonstrated
in Fig. 3, which shows well-resolved resonances of a-ATP
(-7.5 ppm), b-ATP (-16 ppm) and c-ATP (-2.5 ppm).
The peak observed at 7 ppm represents PME resonances
and a second peak at 5 ppm represents inorganic phosphate
(Pi), which is a component of the perfusate buffer. It was
not possible in any of our experiments to resolve bPi
(25 mM) from intra-cellular Pi of the kidney.
Figure 4 represents a 31P spectrum obtained with surface
oxygenation (pO2 *50 kPa). We observe PME and Pi
peaks as well as a significant decrease of ATP level.
If we decrease the pO2 even further to *20 kPa corre-
sponding to the CSS condition (Fig. 5) we observe a PME
peak, Pi and also a small peak at -8 ppm, the signature of
NAD/NADH products. There was no detectable ATP level.
The assessment of the metabolite concentration using the
bPi area as an external reference yields an ATP (b-ATP)
concentration of 1.3 mM with 100 kPa of pO2. The PME
level was 2.9 mM with pO2 of 100 kPa, 3.6 mM with pO2
of 50 kPa and 3.4 mM with pO2 of 20 kPa. These results
are summarized in Table 1, which represents averages and
standard deviation (n = 3) of the metabolite levels.
Figure 6 illustrates the effects of cold ischemia and
reperfusion on ATP level after an initial period of O2?HPP.
The first 31P acquisition (Fig. 6a) represents semi-quantita-
tive evaluation of the PME and ATP levels upon O2?HPP.
The second acquisition (Fig. 6b) was realized after an addi-
tional 10 h of CSS, corresponding to cold ischemic condi-
tion. ATP is not visible, only PME and NAD(H) resonances
are present. Finally, the kidney was re-perfused for 8 more
hours with O2?HPP (Fig. 6c). This third acquisition was
realized 26 h after surgery. In this situation, ATP was clearly
detected again, and was almost back to pre-ischemic level.
Discussion
A prerequisite for successful kidney transplantation is the







Fig. 2 a Sagital scout image
showing the kidney position in
the perfusor. The kidneys are
placed on a holder 2.5 cm from
the coil to avoid RF hot spots
and magnetic field
inhomogeneities. The CSI slice
thickness was 2.5 cm (dashed
line). Kidneys were surrounded
by preservation fluid. b Coronal
T2 image with the
superimposed CSI grid. 31P
spectra were obtained by voxel
averaging over the kidney,
excluding the hilus (white box)
Fig. 3 31P CSI spectra of a kidney during HPP with O2 pressure of
100 kPascal. The 3 ATP resonances are detected at -16 ppm (b-ATP),
-7.3 ppm (a-ATP) and -2.3 ppm (c-ATP). Inorganic phosphate (Pi)
resonates at 5.2 ppm. The Pi peak has been normalized to a value of 1
for comparison. PME peak (Membrane phospholipids, sugar phosphate
and AMP) is identified at 7 ppm. The chemical shift of Pi (5.2 ppm) was
used as reference. Gaussian line fitting is overlaid in dotted line
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storage method. CSS together with preservation fluid
(Viaspan) can safely preserve kidneys from brain dead
donors (presenting no WI) up to 30 h.
With the advent of marginal organ transplantation (DCD
and elderly donors), unknown factors such as prolonged
ischemia may further alter kidney function. Therefore,
reliable assessment of organ viability before transplanta-
tion becomes critical.
31P MRS was proposed decades ago as a means to non-
invasively assess the viability of grafts prior to transplan-
tation. After reperfusion, viable cells should be able to
rephosphorylate AMP present in the PME to ATP. Thus,
high PME may reflect in part energetic reserve for ATP
resynthesis. Therefore, the ratio PME/Pi was suggested as a
marker for organ viability [6, 9]. However, this ratio is
difficult to assess in practice, because first, the observed
organ Pi (oPi) resonance receives contribution from intra-
and extra-cellular components and the difference in pH
cannot necessarily separate the two entities, and second,
the PME peak is made of various chemicals, which may
counterbalance each other. Improved spectral resolution
and the use of CSI may improve the resolution of intra- and
extra-cellular Pi components [8]. Nevertheless, the
assessment of intra-cellular Pi is still dependent upon the
magnetic field homogeneity, with can vary drastically
across the field of view as well as from one examination to
another, leading to measurement inconsistency. We used a
preservation fluid with a fairly high concentration of
phosphate (25 mM), and with constant pH (pH = 7.35).
Measurements with a pH meter done before and after the
experiment confirmed that the pH remained high (less than
0.3 pH unit variation after 24 h of perfusion). Under these
conditions, it is not possible to resolve bPi from oPi peaks.
A simple simulation taking into account the field homo-
geneity typically present in our experiments and a maxi-
mum Pi shift of 0.7 ppm (corresponding to ischemic
conditions with a pH of 6.8) shows that organ Pi concen-
tration should be at least equal to the buffer phosphate
concentration in order to resolve both resonances. We are
far from this situation, and one way to improve intracel-
lular Pi assessment would consist in using phosphate-free
buffer [8]. Unfortunately, such solutions are not well-suited
for perfused organ preservation used in transplantation.
The use of the PME peak to indirectly assess AMP is
also limited due to overlapping resonances. One way to
improve the spectral resolution of the PME peak is to use
Fig. 4 31P CSI spectra of a kidney during HPP with surface
oxygenation (pO2: 50 kPa). Only Pi (truncated, normalized to 1)
and PME are visible. The three ATP resonances are visible, but with




Fig. 5 31P CSI spectra of a kidney during CSS without oxygen (pO2:
20 kPa). Only Pi (truncated, normalized to 1) and PME are visible,
with a slight MAD(H) residue (-7.8 ppm)
Table 1 PME and ATP levels in mM of perfused kidneys with respect to O2 pressure
Oxygen pressure PME oPi c-ATP a-ATP?NAD(H) b-ATP Time of perfusion
pO2 \20 kPa 3.36 (0.35) 21.89 (2.35) – 0.21 (0.09) – 8 h
pO2 = 50 kPa 3.62 (0.60) 22.12 (1.98) 0.42 (0.25) 0.59 (0.25) 0.57 (0.28) 8 h
pO2 = 100 kPa 2.89 (0.77) 21.99 (2.34) 1.17 (0.28) 2.09 (0.33) 1.32 (0.11) 8 h
The values are given as mean mM ± standard deviation (in brackets). The metabolite levels were normalized to the buffer Pi area estimated at
25 mM, after correction for coil sensitivity profile. No correction for signal saturation was performed
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1H decoupling [25]. This requires additional hardware,
which is not available on our current setup.
31P ATP synthesis has been demonstrated in the past,
under arterial blood perfusion applied immediately after
kidney harvesting [26], but this model has no clinical
application. In our study, we show that ATP can be
detected by 31P CSI under fully clinical kidney preserva-
tion conditions, if appropriate O2 tension is applied to the
preservation medium. This approach provides direct evi-
dence of cell bioenergetics and hence organ viability. In
addition, the measure of ATP by 31P MRS is much easier
than the measurement of intracellular Pi and AMP (no
overlapping resonances) and should improve the assess-
ment of organ viability before transplantation.
The attempt to assess ATP concentration yields a value
of 1.3 mM, which is lower than values around 2 mM
reported in vivo [27, 28]. These low values may be related
to hypothermia where the metabolic activity is reduced to
10–15 % of the normal level. It is also possible that ATP is
not fully regenerated by O2?HPP because of cell ischemia
and mitochondrial damage that could have occurred before
harvesting [12]. On the other hand, the PME value
(2.9 mM) is more elevated than the concentrations found in
vivo by the same groups (2.6 ± 0.31 mM). A possible
explanation is that a portion of ATP is already dephos-
phorylated to AMP which gives rise to PME. It is of
interest to note that PME is even more elevated with
reduced oxygen pressure. ATP concentration was based on
b-ATP area because it is the only resonance that represents
exclusively ATP: c- and a-ATP peaks may have a contri-
bution form ADP, and a-ATP shares the same resonance
than NAD(H). In our current experimental conditions, we
have observed a smaller c-ATP resonance than b-ATP
(Table 1), which is unlikely to occur. One possible expla-
nation may be due to relative T1 difference between ATP
moieties, as shown in muscle [29]. Another possible,
indeed more likely, explanation comes from incomplete
baseline correction, which underestimates the c-ATP area.
The error on c-ATP can be avoided by the use of non-
selective hard pulse to reduce the acquisition delay.
Although preliminary, these findings suggest that the bPi
peak integral may provide a simple means to assess the
metabolite concentration of kidneys before transplantation.
The goal in this study was to normalize the data in order to
compare the findings from different experimental condi-
tions rather than provide absolute concentrations. In par-
ticular, we did not take into account differences in
longitudinal relaxation time (T1) of the metabolites with
respect to bPi. T1 effect is difficult to correct as it depends
on the chemical compounds, temperature, organ status
(ischemia) and sequence parameters (TR, flip angle). In
addition, T1 measurement would need excessing mea-
surement time, during which the stability of the metabolite
levels could not be guarantied (although slow, metabolite
levels may decrease under O2?HHP). However, although
not absolutely quantitative, our experimental conditions
(constant T1 and small flip angle) are likely to provide
consistent data allowing the assessment of ATP under
different kidney conditions.
This semi-quantitative approach further demonstrates
the ability for ATP to resynthesize upon oxygenated per-
fusion. Figure 6 reports a follow-up experiment conducted
on one of the kidney perfused immediately after harvesting
and followed for 26 h. After an initial period of O2?HPP,
where ATP could be detected, a prolonged cold ischemic
period of 10 h was carried out showing a full depletion of
ATP. We observed an almost complete recovery of ATP
(*80 %) after another 8 h of O2?HPP. This finding has
important clinical implication in the sense that cell
metabolism seems to be preserved during cold ischemia, at
least if the organ is subjected to prior O2?HPP storage.
Here, we observe a resynthesis of ATP in the absence of
WI. However, it has been reported that better ATP recov-
ery and graft function might be achieved with machine
perfusion even when the organ is subjected to various
periods of WI [30].
In the present study, bPi was measured from voxels
containing no kidney tissue. The advantage of using bPi is
that phosphorus concentration is known exactly (25 mM).
However, correction for the sensitivity profile of the coil
must be introduced to account for differences in voxel
location between the kidney and the reference. The sensi-
tivity profile was obtained from the same CSI acquisition
without kidneys. The bPi area from each voxel contained in
the slice of interest was then mapped (Fig. 7a, b). Because
Fig. 6 Semi-quantitative 31P assessment of kidney metabolites
obtained at 8, 18 and 26 h post harvesting, corresponding to 8 h of
O2?HPP (a), followed by 10 h of CSS (b), followed again by 8 h of
O2?HPP (c), respectively. Only PME and NAD(H) were observed
upon CSS (condition without perfusion). ATP resynthesis was
evidenced by 31P CSI when the kidney was reperfused with O2?HPP
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we can assume that the coil load does not change from
experiment to experiment (given the same amount of buf-
fer), a single calibration map was obtained and used for all
measurements. From these measures, organ Pi (oPi) could
be calculated. On average, a concentration of 22 mM was
found (Table 1), which corresponds to 88 % of the bPi
concentration. This value corresponds to the Pi occupancy
within the kidney. It depends on the phosphate solution
used as perfusate and its capacity to diffuse in the kidney
[11]. In our case, oPi is on average 88 % of the bPi, a value
close to the water content of the kidney, which is known to
be between 83 and 89 % depending on cortical or medullar
tissue [31, 32]. Furthermore, the comparison between the
Pi profile within the kidney (Fig. 7c, d) and the profile of
the empty perfusor (Fig. 7a, b) shows that Pi content is
only slightly reduced. Integral difference of Pi distribution
(Fig. 7e) shows that oPi is between 81 and 89 % of the bPi.
This consistent result confirms that the phosphate solution
used in the present study diffuses freely through the cap-
illary bed into the interstitial space and equilibrium is
attained between intra- an extra-cellular space [20, 21]. As
a result, oPi as measured in the present study reflects pri-
mary buffer Pi and the intracellular phosphate generated as
an end product of energy metabolism contributes only
partially to the MR peak. In the future, we will further
investigate whether oPi could be used as an internal ref-
erence for quantification. The later approach, if valid,
would avoid the need to correct for coil sensitivity profile.
Fig. 7 31P sensitivity profile of the coil. a, b Represent the isocontour
and mesh plots of the empty perfusor, c, d represent the profile with 2
kidneys in the perfusor (one under simple cold storage (CSS), and the
other under oxygenated HPP). From the individual profiles (e) corre-
sponding to the cross section depicted in c, oPi concentration could be
computed. 89 % of the bPi was present in the perfused kidney, and
81 % of the bPi was in the CSS kidney (solid line: empty; dashed
line: with kidneys). The black boxes in e indicate the kidneys’
location
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The present findings constitute the normal basis for
standard kidney harvesting, presenting no WI after 8 h of
O2?HPP. Because perfusion is not halted during the MRI/
MRS procedure, the long acquisition time does not affect
clinical routine. Our experimental setup is completely
transferable to human applications, and can be fully inte-
grated into the clinical workout of kidney transplantation
from marginal donors.
Conclusion
In this paper, we have shown that on kidneys presenting no
WI, ATP analysis can be realized during O2?HPP. The
presence of enough O2 (100 kPa) is necessary for its
resynthesis. Thanks to our new perfusion technology, it is
possible to assess ‘‘in line’’ the ATP amount, which provides
an absolute proof of cell viability. We have shown here the
different energetic states of cold preserved organs taking in
consideration HPP and Oxygenation. This technology may
be used with any clinical MRI machine equipped with 31P
spectroscopy and appears as a powerful tool to study various
preservation conditions as well as warm ischemic effects.
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